DE3855807T2 - Einen Tetra-Polyol enthaltendes Impfstoff-Adjuvans - Google Patents

Einen Tetra-Polyol enthaltendes Impfstoff-Adjuvans

Info

Publication number
DE3855807T2
DE3855807T2 DE3855807T DE3855807T DE3855807T2 DE 3855807 T2 DE3855807 T2 DE 3855807T2 DE 3855807 T DE3855807 T DE 3855807T DE 3855807 T DE3855807 T DE 3855807T DE 3855807 T2 DE3855807 T2 DE 3855807T2
Authority
DE
Germany
Prior art keywords
emulsion
amount
polyol
vaccine adjuvant
tetra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3855807T
Other languages
English (en)
Other versions
DE3855807D1 (de
Inventor
Anthony Clifford Allison
Noelene Elva Byars
Cherng-Chyi Fu
Deborah Marilyn Lidgate
Philip Lewis Felgner
Linda Cheryl Foster
William Alfred Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of DE3855807D1 publication Critical patent/DE3855807D1/de
Application granted granted Critical
Publication of DE3855807T2 publication Critical patent/DE3855807T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
DE3855807T 1987-11-03 1988-11-02 Einen Tetra-Polyol enthaltendes Impfstoff-Adjuvans Expired - Fee Related DE3855807T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11642587A 1987-11-03 1987-11-03

Publications (2)

Publication Number Publication Date
DE3855807D1 DE3855807D1 (de) 1997-04-03
DE3855807T2 true DE3855807T2 (de) 1997-06-12

Family

ID=22367122

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3889521T Expired - Fee Related DE3889521T2 (de) 1987-11-03 1988-11-02 Impfstoff-Adjuvans.
DE3855807T Expired - Fee Related DE3855807T2 (de) 1987-11-03 1988-11-02 Einen Tetra-Polyol enthaltendes Impfstoff-Adjuvans

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3889521T Expired - Fee Related DE3889521T2 (de) 1987-11-03 1988-11-02 Impfstoff-Adjuvans.

Country Status (11)

Country Link
EP (2) EP0315153B1 (de)
JP (2) JP2746272B2 (de)
AT (1) ATE149091T1 (de)
AU (1) AU626271B2 (de)
CA (1) CA1338618C (de)
DE (2) DE3889521T2 (de)
ES (2) ES2097840T3 (de)
HU (1) HU210825A9 (de)
IE (1) IE63692B1 (de)
NZ (1) NZ226811A (de)
ZA (1) ZA888209B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
ES2053402B1 (es) * 1993-01-15 1995-02-01 Hipra Lab Sa Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo.
DE4333376C2 (de) * 1993-09-30 1995-09-07 Gerbu Biotechnik Gmbh Mittel zur Steigerung der Ausbeute von Antikörpern in der Immunologie
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
ES2242604T3 (es) 1999-02-26 2005-11-16 Chiron Corporation Microemulsiones con macroparticulas y microparticulas adsorbidas.
US7854934B2 (en) 1999-08-20 2010-12-21 Sloan-Kettering Institute For Cancer Research Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
AU6921300A (en) 1999-08-20 2001-03-19 Sloan-Kettering Institute For Cancer Research Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
US7824687B2 (en) 1999-08-20 2010-11-02 Sloan-Kettering Institute For Cancer Research Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
AU770475B2 (en) * 1999-12-23 2004-02-19 Aphton Corporation A stable immunogenic composition for frozen storage
FR2804026B1 (fr) * 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
RU2541809C2 (ru) 2003-04-04 2015-02-20 Зоетис Пи ЛЛК Микрофлюидизированные эмульсии "масло в воде" и композиции вакцины
AU2011265184B2 (en) 2010-06-11 2016-08-04 Sloan-Kettering Institute For Cancer Research Multivalent glycopeptide constructs and uses thereof
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
DE3750176T2 (de) * 1986-09-22 1994-10-13 Univ Emory Impfstoff und verfahren zur herstellung.

Also Published As

Publication number Publication date
EP0315153B1 (de) 1994-05-11
AU626271B2 (en) 1992-07-30
EP0513861A1 (de) 1992-11-19
AU2458888A (en) 1989-05-04
IE63692B1 (en) 1995-05-31
CA1338618C (en) 1996-10-01
ES2052674T3 (es) 1994-07-16
IE883305L (en) 1989-05-03
EP0513861B1 (de) 1997-02-26
NZ226811A (en) 1991-06-25
ATE149091T1 (de) 1997-03-15
JPH1053535A (ja) 1998-02-24
DE3855807D1 (de) 1997-04-03
DE3889521T2 (de) 1994-12-08
ZA888209B (en) 1990-07-25
JP2746272B2 (ja) 1998-05-06
JP2816337B2 (ja) 1998-10-27
EP0315153A2 (de) 1989-05-10
DE3889521D1 (de) 1994-06-16
JPH01157918A (ja) 1989-06-21
EP0315153A3 (en) 1989-08-09
ES2097840T3 (es) 1997-04-16
HU210825A9 (en) 1995-08-28

Similar Documents

Publication Publication Date Title
DE3855807D1 (de) Einen Tetra-Polyol enthaltendes Impfstoff-Adjuvans
ATE95425T1 (de) Impfstofformulierung.
AU4897590A (en) Tocols as adjuvant in vaccine
UA49814C2 (uk) Композиція, яка містить антиген вірусу папіломи, спосіб лікування цервікального раку, спосіб лікування гострокінцевої кондиломи
EP0489153A4 (en) Vaccine compositions containing liposomes
LU91486I2 (fr) Emulsion huile-dans-eau comprenant du squalène, duDL-a-tocophérol et du polysorbate 80
ES2081102T5 (es) Vacuna para el herpes simple compuesta por glicoproteina gd del hsv y lipido a de monofosforilo 3-desacilado.
DE68904538T2 (de) Schweisshemmendes mittel.
DK1140165T3 (da) Fordbedrede adjuvanssammensætninger baseret på saponin og dermed tilhörende metoder
DE69010574D1 (de) Hilfsmittelformulierung die eine Emulsion mit submikronischen Oeltropfen enthält.
FI20011187A (fi) Antigeenin kanssa käytettäväksi tarkoitettuja koostumuksia
NL300188I1 (nl) Acellulair vaccin.
ES8502870A1 (es) Un metodo de preparar una vacuna viva
DK0792165T3 (da) Immunogene præparater
FR2425856B1 (de)
ES2053402A1 (es) Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee